<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d438">
    <sentence id="DDI-DrugBank.d438.s0" text="In vitro studies were conducted to investigate the potential of gabapentin to inhibit the major cytochrome P450 enzymes (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) that mediate drug and xenobiotic metabolism using isoform selective marker substrates and human liver microsomal preparations.">
        <entity charOffset="64-73" id="DDI-DrugBank.d438.s0.e0" text="gabapentin" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s1" text="Only at the highest concentration tested (171"/>
    <sentence id="DDI-DrugBank.d438.s2" text="g/mL;"/>
    <sentence id="DDI-DrugBank.d438.s3" text="1 mM) was a slight degree of inhibition (14%-30%) of isoform CYP2A6 observed."/>
    <sentence id="DDI-DrugBank.d438.s4" text="No inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 mg/mL (approximately 15 times the Cmax at 3600 mg/day).">
        <entity charOffset="66-75" id="DDI-DrugBank.d438.s4.e0" text="gabapentin" type="drug"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; inhibition of any of the other isoforms tested was observed at gabapentin concentrations up to 171 mg/mL (approximately 15 times the Cmax at 3600 mg/day). &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s5" text="Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.">
        <entity charOffset="0-9" id="DDI-DrugBank.d438.s5.e0" text="Gabapentin" type="drug"/>
        <entity charOffset="111-129" id="DDI-DrugBank.d438.s5.e1" text="antiepileptic drugs" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s5.e0" e2="DDI-DrugBank.d438.s5.e1" id="DDI-DrugBank.d438.s5.p0"/>
    <negationtags>Gabapentin is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s6" text="The drug interaction data described in this section were obtained from studies involving healthy adults and adult patients with epilepsy."/>
    <sentence id="DDI-DrugBank.d438.s7" text="Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.">
        <entity charOffset="0-8" id="DDI-DrugBank.d438.s7.e0" text="Phenytoin" type="drug"/>
        <entity charOffset="72-80" id="DDI-DrugBank.d438.s7.e1" text="Neurontin" type="brand"/>
        <entity charOffset="124-132" id="DDI-DrugBank.d438.s7.e2" text="phenytoin" type="drug"/>
        <entity charOffset="169-178" id="DDI-DrugBank.d438.s7.e3" text="gabapentin" type="drug"/>
        <entity charOffset="246-254" id="DDI-DrugBank.d438.s7.e4" text="phenytoin" type="drug"/>
        <entity charOffset="260-268" id="DDI-DrugBank.d438.s7.e5" text="phenytoin" type="drug"/>
        <entity charOffset="287-296" id="DDI-DrugBank.d438.s7.e6" text="gabapentin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e0" e2="DDI-DrugBank.d438.s7.e1" id="DDI-DrugBank.d438.s7.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e0" e2="DDI-DrugBank.d438.s7.e2" id="DDI-DrugBank.d438.s7.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e0" e2="DDI-DrugBank.d438.s7.e3" id="DDI-DrugBank.d438.s7.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e0" e2="DDI-DrugBank.d438.s7.e4" id="DDI-DrugBank.d438.s7.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e0" e2="DDI-DrugBank.d438.s7.e5" id="DDI-DrugBank.d438.s7.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e0" e2="DDI-DrugBank.d438.s7.e6" id="DDI-DrugBank.d438.s7.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e1" e2="DDI-DrugBank.d438.s7.e2" id="DDI-DrugBank.d438.s7.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e1" e2="DDI-DrugBank.d438.s7.e3" id="DDI-DrugBank.d438.s7.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e1" e2="DDI-DrugBank.d438.s7.e4" id="DDI-DrugBank.d438.s7.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e1" e2="DDI-DrugBank.d438.s7.e5" id="DDI-DrugBank.d438.s7.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e1" e2="DDI-DrugBank.d438.s7.e6" id="DDI-DrugBank.d438.s7.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e2" e2="DDI-DrugBank.d438.s7.e3" id="DDI-DrugBank.d438.s7.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e2" e2="DDI-DrugBank.d438.s7.e4" id="DDI-DrugBank.d438.s7.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e2" e2="DDI-DrugBank.d438.s7.e5" id="DDI-DrugBank.d438.s7.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e2" e2="DDI-DrugBank.d438.s7.e6" id="DDI-DrugBank.d438.s7.p14"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e3" e2="DDI-DrugBank.d438.s7.e4" id="DDI-DrugBank.d438.s7.p15"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e3" e2="DDI-DrugBank.d438.s7.e5" id="DDI-DrugBank.d438.s7.p16"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e3" e2="DDI-DrugBank.d438.s7.e6" id="DDI-DrugBank.d438.s7.p17"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e4" e2="DDI-DrugBank.d438.s7.e5" id="DDI-DrugBank.d438.s7.p18"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e4" e2="DDI-DrugBank.d438.s7.e6" id="DDI-DrugBank.d438.s7.p19"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s7.e5" e2="DDI-DrugBank.d438.s7.e6" id="DDI-DrugBank.d438.s7.p20"/>
    <negationtags>Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s8" text="Carbamazepine: Steady-state trough plasma carbamazepine and carbamazepine 10, 11 epoxide concentrations were not affected by concomitant gabapentin (400 mg TID;">
        <entity charOffset="0-12" id="DDI-DrugBank.d438.s8.e0" text="Carbamazepine" type="drug"/>
        <entity charOffset="42-54" id="DDI-DrugBank.d438.s8.e1" text="carbamazepine" type="drug"/>
        <entity charOffset="60-87" id="DDI-DrugBank.d438.s8.e2" text="carbamazepine 10, 11 epoxide" type="drug_n"/>
        <entity charOffset="137-146" id="DDI-DrugBank.d438.s8.e3" text="gabapentin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s8.e0" e2="DDI-DrugBank.d438.s8.e1" id="DDI-DrugBank.d438.s8.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s8.e0" e2="DDI-DrugBank.d438.s8.e2" id="DDI-DrugBank.d438.s8.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s8.e0" e2="DDI-DrugBank.d438.s8.e3" id="DDI-DrugBank.d438.s8.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s8.e1" e2="DDI-DrugBank.d438.s8.e2" id="DDI-DrugBank.d438.s8.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s8.e1" e2="DDI-DrugBank.d438.s8.e3" id="DDI-DrugBank.d438.s8.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s8.e2" e2="DDI-DrugBank.d438.s8.e3" id="DDI-DrugBank.d438.s8.p5"/>
    <negationtags>Carbamazepine: Steady-state trough plasma carbamazepine and carbamazepine 10, 11 epoxide concentrations were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affected by concomitant gabapentin (400 mg TID; &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s9" text="N=12) administration."/>
    <sentence id="DDI-DrugBank.d438.s10" text="Likewise, gabapentin pharmacokinetics were unaltered by carbamazepine administration.">
        <entity charOffset="10-19" id="DDI-DrugBank.d438.s10.e0" text="gabapentin" type="drug"/>
        <entity charOffset="56-68" id="DDI-DrugBank.d438.s10.e1" text="carbamazepine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s10.e0" e2="DDI-DrugBank.d438.s10.e1" id="DDI-DrugBank.d438.s10.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s11" text="Valproic Acid: The mean steady-state trough serum valproic acid concentrations prior to and during concomitant gabapentin administration (400 mg TID;">
        <entity charOffset="0-12" id="DDI-DrugBank.d438.s11.e0" text="Valproic Acid" type="drug"/>
        <entity charOffset="50-62" id="DDI-DrugBank.d438.s11.e1" text="valproic acid" type="drug"/>
        <entity charOffset="111-120" id="DDI-DrugBank.d438.s11.e2" text="gabapentin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s11.e0" e2="DDI-DrugBank.d438.s11.e1" id="DDI-DrugBank.d438.s11.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s11.e0" e2="DDI-DrugBank.d438.s11.e2" id="DDI-DrugBank.d438.s11.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s11.e1" e2="DDI-DrugBank.d438.s11.e2" id="DDI-DrugBank.d438.s11.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s12" text="N=17) were not different and neither were gabapentin pharmacokinetic parameters affected by valproic acid.">
        <entity charOffset="42-51" id="DDI-DrugBank.d438.s12.e0" text="gabapentin" type="drug"/>
        <entity charOffset="92-104" id="DDI-DrugBank.d438.s12.e1" text="valproic acid" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s12.e0" e2="DDI-DrugBank.d438.s12.e1" id="DDI-DrugBank.d438.s12.p0"/>
    <negationtags>N=17) were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; different and neither were gabapentin pharmacokinetic parameters affected by valproic acid. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s13" text="Phenobarbital: Estimates of steady-state pharmacokinetic parameters for phenobarbital or gabapentin (300 mg TID;">
        <entity charOffset="0-12" id="DDI-DrugBank.d438.s13.e0" text="Phenobarbital" type="drug"/>
        <entity charOffset="72-84" id="DDI-DrugBank.d438.s13.e1" text="phenobarbital" type="drug"/>
        <entity charOffset="89-98" id="DDI-DrugBank.d438.s13.e2" text="gabapentin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s13.e0" e2="DDI-DrugBank.d438.s13.e1" id="DDI-DrugBank.d438.s13.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s13.e0" e2="DDI-DrugBank.d438.s13.e2" id="DDI-DrugBank.d438.s13.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s13.e1" e2="DDI-DrugBank.d438.s13.e2" id="DDI-DrugBank.d438.s13.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s14" text="N=12) are identical whether the drugs are administered alone or together."/>
    <sentence id="DDI-DrugBank.d438.s15" text="Naproxen: Coadministration (N=18) of naproxen sodium capsules (250 mg) with Neurontin (125 mg) appears to increase the amount of gabapentin absorbed by 12% to 15%.">
        <entity charOffset="0-7" id="DDI-DrugBank.d438.s15.e0" text="Naproxen" type="drug"/>
        <entity charOffset="37-51" id="DDI-DrugBank.d438.s15.e1" text="naproxen sodium" type="drug"/>
        <entity charOffset="76-84" id="DDI-DrugBank.d438.s15.e2" text="Neurontin" type="brand"/>
        <entity charOffset="129-138" id="DDI-DrugBank.d438.s15.e3" text="gabapentin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s15.e0" e2="DDI-DrugBank.d438.s15.e1" id="DDI-DrugBank.d438.s15.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s15.e0" e2="DDI-DrugBank.d438.s15.e2" id="DDI-DrugBank.d438.s15.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s15.e0" e2="DDI-DrugBank.d438.s15.e3" id="DDI-DrugBank.d438.s15.p2"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s15.e1" e2="DDI-DrugBank.d438.s15.e2" id="DDI-DrugBank.d438.s15.p3" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s15.e1" e2="DDI-DrugBank.d438.s15.e3" id="DDI-DrugBank.d438.s15.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s15.e2" e2="DDI-DrugBank.d438.s15.e3" id="DDI-DrugBank.d438.s15.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s16" text="Gabapentin had no effect on naproxen pharmacokinetic parameters.">
        <entity charOffset="0-9" id="DDI-DrugBank.d438.s16.e0" text="Gabapentin" type="drug"/>
        <entity charOffset="28-35" id="DDI-DrugBank.d438.s16.e1" text="naproxen" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s16.e0" e2="DDI-DrugBank.d438.s16.e1" id="DDI-DrugBank.d438.s16.p0"/>
    <negationtags>Gabapentin had &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; effect on naproxen pharmacokinetic parameters. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s17" text="These doses are lower than the therapeutic doses for both drugs."/>
    <sentence id="DDI-DrugBank.d438.s18" text="The magnitude of interaction within the recommended dose ranges of either drug is not known."><negationtags>The magnitude of interaction within the recommended dose ranges of either drug is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; known. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s19" text="Hydrocodone: Coadministration of Neurontin  (125 to 500 mg;">
        <entity charOffset="0-10" id="DDI-DrugBank.d438.s19.e0" text="Hydrocodone" type="drug"/>
        <entity charOffset="33-41" id="DDI-DrugBank.d438.s19.e1" text="Neurontin" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s19.e0" e2="DDI-DrugBank.d438.s19.e1" id="DDI-DrugBank.d438.s19.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s20" text="N=48) decreases hydrocodone (10 mg;">
        <entity charOffset="16-26" id="DDI-DrugBank.d438.s20.e0" text="hydrocodone" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s21" text="N=50) Cmax and AUC values in a dose-dependent manner relative to administration of hydrocodone alone;">
        <entity charOffset="83-93" id="DDI-DrugBank.d438.s21.e0" text="hydrocodone" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s22" text="Cmax and AUC values are 3% to 4% lower, respectively, after administration of 125 mg Neurontin  and 21% to 22% lower, respectively, after administration of 500 mg Neurontin .">
        <entity charOffset="85-93" id="DDI-DrugBank.d438.s22.e0" text="Neurontin" type="brand"/>
        <entity charOffset="163-171" id="DDI-DrugBank.d438.s22.e1" text="Neurontin" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s22.e0" e2="DDI-DrugBank.d438.s22.e1" id="DDI-DrugBank.d438.s22.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s23" text="The mechanism for this interaction is unknown."/>
    <sentence id="DDI-DrugBank.d438.s24" text="Hydrocodone increases gabapentin AUC values by 14%.">
        <entity charOffset="0-10" id="DDI-DrugBank.d438.s24.e0" text="Hydrocodone" type="drug"/>
        <entity charOffset="22-31" id="DDI-DrugBank.d438.s24.e1" text="gabapentin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s24.e0" e2="DDI-DrugBank.d438.s24.e1" id="DDI-DrugBank.d438.s24.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s25" text="The magnitude of interaction at other doses is not known."><negationtags>The magnitude of interaction at other doses is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; known. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s26" text="Morphine: A literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg Neurontin  capsule (N=12), mean gabapentin AUC increased by 44% compared to gabapentin administered without morphine.">
        <entity charOffset="0-7" id="DDI-DrugBank.d438.s26.e0" text="Morphine" type="drug"/>
        <entity charOffset="77-84" id="DDI-DrugBank.d438.s26.e1" text="morphine" type="drug"/>
        <entity charOffset="137-145" id="DDI-DrugBank.d438.s26.e2" text="Neurontin" type="brand"/>
        <entity charOffset="169-178" id="DDI-DrugBank.d438.s26.e3" text="gabapentin" type="drug"/>
        <entity charOffset="213-222" id="DDI-DrugBank.d438.s26.e4" text="gabapentin" type="drug"/>
        <entity charOffset="245-252" id="DDI-DrugBank.d438.s26.e5" text="morphine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e0" e2="DDI-DrugBank.d438.s26.e1" id="DDI-DrugBank.d438.s26.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e0" e2="DDI-DrugBank.d438.s26.e2" id="DDI-DrugBank.d438.s26.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e0" e2="DDI-DrugBank.d438.s26.e3" id="DDI-DrugBank.d438.s26.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e0" e2="DDI-DrugBank.d438.s26.e4" id="DDI-DrugBank.d438.s26.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e0" e2="DDI-DrugBank.d438.s26.e5" id="DDI-DrugBank.d438.s26.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s26.e1" e2="DDI-DrugBank.d438.s26.e2" id="DDI-DrugBank.d438.s26.p5" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e1" e2="DDI-DrugBank.d438.s26.e3" id="DDI-DrugBank.d438.s26.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e1" e2="DDI-DrugBank.d438.s26.e4" id="DDI-DrugBank.d438.s26.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e1" e2="DDI-DrugBank.d438.s26.e5" id="DDI-DrugBank.d438.s26.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e2" e2="DDI-DrugBank.d438.s26.e3" id="DDI-DrugBank.d438.s26.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e2" e2="DDI-DrugBank.d438.s26.e4" id="DDI-DrugBank.d438.s26.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e2" e2="DDI-DrugBank.d438.s26.e5" id="DDI-DrugBank.d438.s26.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e3" e2="DDI-DrugBank.d438.s26.e4" id="DDI-DrugBank.d438.s26.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e3" e2="DDI-DrugBank.d438.s26.e5" id="DDI-DrugBank.d438.s26.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s26.e4" e2="DDI-DrugBank.d438.s26.e5" id="DDI-DrugBank.d438.s26.p14"/>
    <negationtags>Morphine: A literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg Neurontin capsule (N=12), mean gabapentin AUC increased by 44% compared to gabapentin administered &lt;scope&gt; &lt;cue&gt; without &lt;/cue&gt; morphine. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s27" text="Morphine pharmacokinetic parameter values were not affected by administration of Neurontin  2 hours after morphine.">
        <entity charOffset="0-7" id="DDI-DrugBank.d438.s27.e0" text="Morphine" type="drug"/>
        <entity charOffset="81-89" id="DDI-DrugBank.d438.s27.e1" text="Neurontin" type="brand"/>
        <entity charOffset="106-113" id="DDI-DrugBank.d438.s27.e2" text="morphine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s27.e0" e2="DDI-DrugBank.d438.s27.e1" id="DDI-DrugBank.d438.s27.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s27.e0" e2="DDI-DrugBank.d438.s27.e2" id="DDI-DrugBank.d438.s27.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s27.e1" e2="DDI-DrugBank.d438.s27.e2" id="DDI-DrugBank.d438.s27.p2"/>
    <negationtags>Morphine pharmacokinetic parameter values were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affected by administration of Neurontin 2 hours after morphine. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s28" text="The magnitude of interaction at other doses is not known."><negationtags>The magnitude of interaction at other doses is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; known. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s29" text="Cimetidine: In the presence of cimetidine at 300 mg QID (N=12) the mean apparent oral clearance of gabapentin fell by 14% and creatinine clearance fell by 10%.">
        <entity charOffset="0-9" id="DDI-DrugBank.d438.s29.e0" text="Cimetidine" type="drug"/>
        <entity charOffset="31-40" id="DDI-DrugBank.d438.s29.e1" text="cimetidine" type="drug"/>
        <entity charOffset="99-108" id="DDI-DrugBank.d438.s29.e2" text="gabapentin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s29.e0" e2="DDI-DrugBank.d438.s29.e1" id="DDI-DrugBank.d438.s29.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s29.e0" e2="DDI-DrugBank.d438.s29.e2" id="DDI-DrugBank.d438.s29.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s29.e1" e2="DDI-DrugBank.d438.s29.e2" id="DDI-DrugBank.d438.s29.p2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s30" text="Thus cimetidine appeared to alter the renal excretion of both gabapentin and creatinine, an endogenous marker of renal function.">
        <entity charOffset="5-14" id="DDI-DrugBank.d438.s30.e0" text="cimetidine" type="drug"/>
        <entity charOffset="62-71" id="DDI-DrugBank.d438.s30.e1" text="gabapentin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s30.e0" e2="DDI-DrugBank.d438.s30.e1" id="DDI-DrugBank.d438.s30.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s31" text="This small decrease in excretion of gabapentin by cimetidine is not expected to be of clinical importance.">
        <entity charOffset="36-45" id="DDI-DrugBank.d438.s31.e0" text="gabapentin" type="drug"/>
        <entity charOffset="50-59" id="DDI-DrugBank.d438.s31.e1" text="cimetidine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s31.e0" e2="DDI-DrugBank.d438.s31.e1" id="DDI-DrugBank.d438.s31.p0" type="mechanism"/>
    <negationtags>This small decrease in excretion of gabapentin by cimetidine is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; expected to be of clinical importance. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s32" text="The effect of gabapentin on cimetidine was not evaluated.">
        <entity charOffset="14-23" id="DDI-DrugBank.d438.s32.e0" text="gabapentin" type="drug"/>
        <entity charOffset="28-37" id="DDI-DrugBank.d438.s32.e1" text="cimetidine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s32.e0" e2="DDI-DrugBank.d438.s32.e1" id="DDI-DrugBank.d438.s32.p0"/>
    <negationtags>The effect of gabapentin on cimetidine was &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; evaluated. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s33" text="Oral Contraceptive: Based on AUC and half-life, multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin (400 mg TID;">
        <entity charOffset="5-17" id="DDI-DrugBank.d438.s33.e0" text="Contraceptive" type="group"/>
        <entity charOffset="90-102" id="DDI-DrugBank.d438.s33.e1" text="norethindrone" type="drug"/>
        <entity charOffset="108-124" id="DDI-DrugBank.d438.s33.e2" text="ethinyl estradiol" type="drug"/>
        <entity charOffset="183-203" id="DDI-DrugBank.d438.s33.e3" text="norethindrone acetate" type="drug"/>
        <entity charOffset="219-235" id="DDI-DrugBank.d438.s33.e4" text="ethinyl estradiol" type="drug"/>
        <entity charOffset="287-296" id="DDI-DrugBank.d438.s33.e5" text="gabapentin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e0" e2="DDI-DrugBank.d438.s33.e1" id="DDI-DrugBank.d438.s33.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e0" e2="DDI-DrugBank.d438.s33.e2" id="DDI-DrugBank.d438.s33.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e0" e2="DDI-DrugBank.d438.s33.e3" id="DDI-DrugBank.d438.s33.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e0" e2="DDI-DrugBank.d438.s33.e4" id="DDI-DrugBank.d438.s33.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e0" e2="DDI-DrugBank.d438.s33.e5" id="DDI-DrugBank.d438.s33.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e1" e2="DDI-DrugBank.d438.s33.e2" id="DDI-DrugBank.d438.s33.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e1" e2="DDI-DrugBank.d438.s33.e3" id="DDI-DrugBank.d438.s33.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e1" e2="DDI-DrugBank.d438.s33.e4" id="DDI-DrugBank.d438.s33.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e1" e2="DDI-DrugBank.d438.s33.e5" id="DDI-DrugBank.d438.s33.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e2" e2="DDI-DrugBank.d438.s33.e3" id="DDI-DrugBank.d438.s33.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e2" e2="DDI-DrugBank.d438.s33.e4" id="DDI-DrugBank.d438.s33.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e2" e2="DDI-DrugBank.d438.s33.e5" id="DDI-DrugBank.d438.s33.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e3" e2="DDI-DrugBank.d438.s33.e4" id="DDI-DrugBank.d438.s33.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e3" e2="DDI-DrugBank.d438.s33.e5" id="DDI-DrugBank.d438.s33.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s33.e4" e2="DDI-DrugBank.d438.s33.e5" id="DDI-DrugBank.d438.s33.p14"/>
    <negationtags>Oral Contraceptive: Based on AUC and half-life, multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and &lt;scope&gt; &lt;cue&gt; without &lt;/cue&gt; coadministration of gabapentin (400 mg TID; &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s34" text="N=13)."/>
    <sentence id="DDI-DrugBank.d438.s35" text="The Cmax of norethindrone was 13% higher when it was coadministered with gabapentin;">
        <entity charOffset="12-24" id="DDI-DrugBank.d438.s35.e0" text="norethindrone" type="drug"/>
        <entity charOffset="73-82" id="DDI-DrugBank.d438.s35.e1" text="gabapentin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s35.e0" e2="DDI-DrugBank.d438.s35.e1" id="DDI-DrugBank.d438.s35.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s36" text="this interaction is not expected to be of clinical importance."><negationtags>this interaction is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; expected to be of clinical importance. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s37" text="Antacid (Maalox ): Maalox reduced the bioavailability of gabapentin (N=16) by about 20%.">
        <entity charOffset="0-6" id="DDI-DrugBank.d438.s37.e0" text="Antacid" type="group"/>
        <entity charOffset="9-14" id="DDI-DrugBank.d438.s37.e1" text="Maalox" type="brand"/>
        <entity charOffset="19-24" id="DDI-DrugBank.d438.s37.e2" text="Maalox" type="brand"/>
        <entity charOffset="57-66" id="DDI-DrugBank.d438.s37.e3" text="gabapentin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s37.e0" e2="DDI-DrugBank.d438.s37.e1" id="DDI-DrugBank.d438.s37.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s37.e0" e2="DDI-DrugBank.d438.s37.e2" id="DDI-DrugBank.d438.s37.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s37.e0" e2="DDI-DrugBank.d438.s37.e3" id="DDI-DrugBank.d438.s37.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s37.e1" e2="DDI-DrugBank.d438.s37.e2" id="DDI-DrugBank.d438.s37.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s37.e1" e2="DDI-DrugBank.d438.s37.e3" id="DDI-DrugBank.d438.s37.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s37.e2" e2="DDI-DrugBank.d438.s37.e3" id="DDI-DrugBank.d438.s37.p5" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s38" text="This decrease in bioavailability was about 5% when gabapentin was administered 2 hours after Maalox.">
        <entity charOffset="51-60" id="DDI-DrugBank.d438.s38.e0" text="gabapentin" type="drug"/>
        <entity charOffset="93-98" id="DDI-DrugBank.d438.s38.e1" text="Maalox" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s38.e0" e2="DDI-DrugBank.d438.s38.e1" id="DDI-DrugBank.d438.s38.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s39" text="It is recommended that gabapentin be taken at least 2 hours following Maalox administration.">
        <entity charOffset="23-32" id="DDI-DrugBank.d438.s39.e0" text="gabapentin" type="drug"/>
        <entity charOffset="70-75" id="DDI-DrugBank.d438.s39.e1" text="Maalox" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d438.s39.e0" e2="DDI-DrugBank.d438.s39.e1" id="DDI-DrugBank.d438.s39.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s40" text="Effect of Probenecid: Probenecid is a blocker of renal tubular secretion.">
        <entity charOffset="10-19" id="DDI-DrugBank.d438.s40.e0" text="Probenecid" type="drug"/>
        <entity charOffset="22-31" id="DDI-DrugBank.d438.s40.e1" text="Probenecid" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s40.e0" e2="DDI-DrugBank.d438.s40.e1" id="DDI-DrugBank.d438.s40.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d438.s41" text="Gabapentin pharmacokinetic parameters without and with probenecid were comparable.">
        <entity charOffset="0-9" id="DDI-DrugBank.d438.s41.e0" text="Gabapentin" type="drug"/>
        <entity charOffset="55-64" id="DDI-DrugBank.d438.s41.e1" text="probenecid" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s41.e0" e2="DDI-DrugBank.d438.s41.e1" id="DDI-DrugBank.d438.s41.p0"/>
    <negationtags>Gabapentin pharmacokinetic parameters &lt;scope&gt; &lt;cue&gt; without &lt;/cue&gt; and with probenecid were comparable. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s42" text="This indicates that gabapentin does not undergo renal tubular secretion by the pathway that is blocked by probenecid.">
        <entity charOffset="20-29" id="DDI-DrugBank.d438.s42.e0" text="gabapentin" type="drug"/>
        <entity charOffset="106-115" id="DDI-DrugBank.d438.s42.e1" text="probenecid" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s42.e0" e2="DDI-DrugBank.d438.s42.e1" id="DDI-DrugBank.d438.s42.p0"/>
    <negationtags>This indicates that gabapentin does &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; undergo renal tubular secretion by the pathway that is blocked by probenecid. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s43" text="Drug/Laboratory Tests Interactions Because false positive readings were reported with the Ames N-Multistix SG dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein">
        <entity charOffset="149-158" id="DDI-DrugBank.d438.s43.e0" text="gabapentin" type="drug"/>
        <entity charOffset="179-197" id="DDI-DrugBank.d438.s43.e1" text="antiepileptic drugs" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d438.s43.e0" e2="DDI-DrugBank.d438.s43.e1" id="DDI-DrugBank.d438.s43.p0"/>
    <negationtags>Drug/Laboratory Tests Interactions Because false positive readings were reported with the Ames N-Multistix SG dipstick &lt;scope&gt; &lt;cue&gt; test for &lt;/cue&gt; urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d438.s44" text="."/>
    <sentence id="DDI-DrugBank.d438.s45" text=""/>
</document>